Trulieve Q4 revenue $301M (+5% YoY), gross margin 62%; FY2024 record FCF $150M

Trulieve Cannabis Corp.

2024-FY EPS reported -$0.79 revenue$1,186,490,000

Q4 2024 revenue $301M, up 5% YoY; gross margin 62% vs 54% in Q4 2023.
FY2024 revenue $1.2B (+5% YoY); GAAP gross profit $716M (60% margin).
FY2024 adjusted EBITDA $420M (35% of revenue), up 30% YoY; record ops cash flow $271M, FCF $150M.
Net loss attributable to common $155M; adjusted net loss $19M (excl. non-recurring items & impairments).
Added 33 dispensaries in 2024 to total 225; launched adult-use sales at three Ohio locations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.